Bhutan vs Norway: Treatment success rate for patients treated for MDR-TB
Bhutan
91.0%
in 2022
Norway
91.0%
in 2022
Bhutan rank
21st
Norway rank
21st
Treatment success rate for patients treated for MDR-TB over time
- Bhutan
- Norway
How they compare
Bhutan currently reports 91.0% against 91.0% in Norway, a difference of 0.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Bhutan ahead.
Bhutan ranks 21st and Norway ranks 21st of 163 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 60.0% | 14.0% | Bhutan |
| 2010s | 92.1% | 74.4% | 17.7% | Bhutan |
| 2020s | 93.0% | 86.0% | 7.0% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bhutan or Norway?
- Bhutan, at 91.0% against 91.0% in Norway as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bhutan and Norway?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Norway?
- 16 years are reported by both, from 2007 to 2022.
- How do Bhutan and Norway rank globally for treatment success rate for patients treated for mdr-tb?
- Bhutan ranks 21st and Norway ranks 21st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.